期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
锶纳米羟基磷灰石原花青素复合涂膜对牙本质小管的封闭作用 被引量:2
1
作者 甄佳秀 杨正艳 +1 位作者 左静 周智 《第三军医大学学报》 CAS CSCD 北大核心 2017年第7期622-627,共6页
目的检测自主合成的锶纳米羟基磷灰石原花青素(strontium-substituted-hydroxyapatite varnish,SrHAP-PA)复合涂膜对牙本质小管的封闭作用。方法首先构建牙本质敏感体外研究模型,并在模拟人口腔环境的条件下检测SrHAP-PA复合涂膜对牙本... 目的检测自主合成的锶纳米羟基磷灰石原花青素(strontium-substituted-hydroxyapatite varnish,SrHAP-PA)复合涂膜对牙本质小管的封闭作用。方法首先构建牙本质敏感体外研究模型,并在模拟人口腔环境的条件下检测SrHAP-PA复合涂膜对牙本质小管的封闭作用,用扫描电镜观察循环结束后各组牙本质小管的封闭情况,X线能谱分析牙本质表面元素变化,记录各组傅里叶红外光谱,并用激光共聚焦扫描显微镜观察药品进入牙本质小管情况。结果成功构建了体外牙本质敏感的模型,并且在扫描电子显微镜下观察到SrHAP-PA复合涂膜能有效地封闭牙本质小管,X线能谱分析检测发现SrHAP-PA复合涂膜促进矿化物的形成,激光共聚焦扫描显微镜观察到该涂膜能快速进入到牙本质小管中,且能保存较长时间。结论以SrHAP-PA复合物为有效成分的涂膜材料能有效封闭牙本质小管。 展开更多
关键词 原花青素 渗透型丙烯酸树脂 涂膜 牙本质过敏 锶纳米羟基磷灰石
下载PDF
Formulation and evaluation of a bioadhesive patch for buccal delivery of tizanidine 被引量:2
2
作者 Mohamed S.Pendekal Pramod K.Tegginamat 《Acta Pharmaceutica Sinica B》 SCIE CAS 2012年第3期318-324,共7页
Tizanidine hydrochloride(THCl)is an antispasmodic agent which undergoes extensive first pass metabolism making it a possible candidate for buccal delivery.The aim of this study was to prepare a monolayered buccal patc... Tizanidine hydrochloride(THCl)is an antispasmodic agent which undergoes extensive first pass metabolism making it a possible candidate for buccal delivery.The aim of this study was to prepare a monolayered buccal patch containing THCl using the emulsification solvent evaporation method.Fourteen formulations were prepared using the polymers Eudragit■ RS 100 or EudragitB RL 100 and chitosan.Polymer solutions in acetone were combined with a THCl aqueous solution(in some cases containing chitosan)by homogenization at 9000 rpm for 2 min in the presence of triethyl citrate as plasticizer and cast in novel Teflon molds.Physicochemical properties such as film thickness,in vitro drug release and in vitro mucoadhesion were evaluated after which permeation across sheep buccal mucosa was examined in terms of flux and lag time.Formulations prepared using a Eudragit■polymer alone exhibited sa tisfactory physicomechanical properties but lacked a gradual in vitro drug release pattern.Incorporation of chitosan into formulations resulted in the formation of a porous structure which did exhibit gradual release of drug.In conclusion,THCl can be delivered by a buccal patch formulated as a blend of Eudragit■ and chitosan,the latter being necessary to achieve gradual drug release. 展开更多
关键词 Tizanidine hydrochloride Buccal patch CHITOSAN eudragits■RS 100 eudragits■RL 100 In vitro drug release In vitro mucoadhesion
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部